Skip to main content
Journal cover image

Strategic use of statistical thinking in drug development.

Publication ,  Journal Article
Rockhold, FW
Published in: Stat Med
December 15, 2000

The role of the statistician and statistical thinking in the pharmaceutical industry has evolved greatly in the last four or five decades. Regulatory developments and the changing face of the science of drug development have driven this evolution. The increasing regulatory requirement for statistical input in critical areas has facilitated a wider range of applications. The pace of change of science in general has brought statisticians into contact with a wider range of potential customers. More importantly, it has allowed the statistician to become increasingly involved in strategic issues with the possibility of influencing the direction of the business. However, it is not clear that the statistical profession in industry is adequately prepared for these opportunities either in attitude or training. Changing the statisticians' approach to their role and acquiring the correct training and experience are critical for the profession to optimize their contribution to the drug discovery and development processes.

Duke Scholars

Published In

Stat Med

DOI

ISSN

0277-6715

Publication Date

December 15, 2000

Volume

19

Issue

23

Start / End Page

3211 / 3217

Location

England

Related Subject Headings

  • Statistics as Topic
  • Statistics & Probability
  • Humans
  • Drug Industry
  • Drug Design
  • Drug Approval
  • 4905 Statistics
  • 4202 Epidemiology
  • 1117 Public Health and Health Services
  • 0104 Statistics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rockhold, F. W. (2000). Strategic use of statistical thinking in drug development. Stat Med, 19(23), 3211–3217. https://doi.org/10.1002/1097-0258(20001215)19:23<3211::aid-sim622>3.0.co;2-f
Rockhold, F. W. “Strategic use of statistical thinking in drug development.Stat Med 19, no. 23 (December 15, 2000): 3211–17. https://doi.org/10.1002/1097-0258(20001215)19:23<3211::aid-sim622>3.0.co;2-f.
Rockhold FW. Strategic use of statistical thinking in drug development. Stat Med. 2000 Dec 15;19(23):3211–7.
Rockhold, F. W. “Strategic use of statistical thinking in drug development.Stat Med, vol. 19, no. 23, Dec. 2000, pp. 3211–17. Pubmed, doi:10.1002/1097-0258(20001215)19:23<3211::aid-sim622>3.0.co;2-f.
Rockhold FW. Strategic use of statistical thinking in drug development. Stat Med. 2000 Dec 15;19(23):3211–3217.
Journal cover image

Published In

Stat Med

DOI

ISSN

0277-6715

Publication Date

December 15, 2000

Volume

19

Issue

23

Start / End Page

3211 / 3217

Location

England

Related Subject Headings

  • Statistics as Topic
  • Statistics & Probability
  • Humans
  • Drug Industry
  • Drug Design
  • Drug Approval
  • 4905 Statistics
  • 4202 Epidemiology
  • 1117 Public Health and Health Services
  • 0104 Statistics